Patents by Inventor Baptiste Aussedat

Baptiste Aussedat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic HIV-1 Env V3 glycopeptide immunogens
    Patent number: 10286057
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and, in particular, to a vaccine for HIV-1, comprising synthetic V3 glycopeptides, and to methods of making and using same.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: May 14, 2019
    Assignees: Duke University, Sloan-Kettering Institute for Cancer Research, Dana-Farber Cancer Institute, Inc.
    Inventors: Barton F. Haynes, Hua-xin Liao, Samuel Danishefsky, Peter Park, Joseph Sodroski, Baptiste Aussedat, Yusuf Vohra
  • V3 IMMUNOGENS
    Publication number: 20160106827
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and, in particular, to a vaccine for HIV-1, comprising synthetic V3 glycopeptides, and to methods of making and using same.
    Type: Application
    Filed: April 15, 2014
    Publication date: April 21, 2016
    Inventors: Barton F. Haynes, Hua-xin Liao, Samuel Danishefsky, Peter Park, Joseph Sodroski, Baptiste Aussedat, Yusuf Vohra
  • SYNTHETIC ENV PROTEINS
    Publication number: 20150283227
    Abstract: The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1), and, in particular to a vaccine for HIV-1 and to methods of making and using same. The present invention provides synthetic glycosylated HIV-1 peptides, method for their preparation and use.
    Type: Application
    Filed: October 28, 2013
    Publication date: October 8, 2015
    Inventors: Barton F. Haynes, Hua-Xin Liao, S. Munir Alam, Samuel Danishefsky, Baptiste Aussedat, Peter K. Park, Yusuf Vohra, Joseph Sodroski